Close Menu

NEW YORK – GenMark Diagnostics reported after the close of the market on Monday that its fourth quarter revenues rose 40 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, 2019, the company reported revenues of $27.2 million, up from $19.4 million in Q4 2018 but missing analysts' consensus estimate of $27.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.